| 36th week of 2016 patent applcation highlights part 7 |
| Patent application number | Title | Published |
|---|
| 20160256359 | Flexible Sealing Lid And Connector Device For A Drink Container | 2016-09-08 |
| 20160256360 | Gastronomy Tube Holder | 2016-09-08 |
| 20160256361 | DENTAL ROOT CANAL FILLING MATERIAL HAVING IMPROVED THERMAL CONDUCTIVE CHARACTERISTICS | 2016-09-08 |
| 20160256362 | Stabilized Calcium Phosphate and Methods of Forming Same | 2016-09-08 |
| 20160256363 | DENTAL COMPOSITION | 2016-09-08 |
| 20160256364 | Hair Conditioning Compositions With Microcapsules | 2016-09-08 |
| 20160256365 | Hair Conditioning Compositions With Microcapsules | 2016-09-08 |
| 20160256366 | COSMETIC TREATMENT WITH NITRIC OXIDE, DEVICE FOR PERFORMING SAID TREATMENT AND MANUFACTURING METHOD THEREFOR | 2016-09-08 |
| 20160256367 | TWO-PHASE COMPOSITION COMPRISING A FATTY ACID ESTER OF SUGAR OR A LIQUID ALKYL POLYGLUCOSIDE, WITH AN HLB < 8, AND A C8-C18 BRANCHED ALKANE | 2016-09-08 |
| 20160256368 | METHODS FOR TREATING SKIN | 2016-09-08 |
| 20160256369 | METHODS FOR TREATING SKIN | 2016-09-08 |
| 20160256370 | HAIR RETENTIVE FORMULATION AND METHOD OF USE | 2016-09-08 |
| 20160256371 | PHOTOSTABLE COMPOSITIONS COMPRISING PARA-ALKOXYL PHENYL SUBSTITUTED PROPENOIC ACID (APP) DERIVATIVES | 2016-09-08 |
| 20160256372 | NANOPARTICLE SYSTEM COMPRISING OIL AND UV FILTER | 2016-09-08 |
| 20160256373 | SECOND AGENT COMPOSITION FOR HAIR DYEING AND BLEACHING | 2016-09-08 |
| 20160256374 | METHODS FOR TREATING HAIR LOSS DISORDERS | 2016-09-08 |
| 20160256375 | COSMETIC PRODUCT WITH DNA-REPAIR PROPERTIES | 2016-09-08 |
| 20160256376 | USE OF GLYCOSAMINOGLYCAN LIPOATE ESTERS IN THE TRICHOLOGY FIELD | 2016-09-08 |
| 20160256377 | LONG-WEAR MASCARA COMPOSITION | 2016-09-08 |
| 20160256378 | MASCARA COMPOSITION | 2016-09-08 |
| 20160256379 | IMPROVED PROTECTION AGAINST EXTRINSIC SKIN AGING | 2016-09-08 |
| 20160256380 | USE OF NATURALLY-OCCURRING BLOOMS CONTAINING TOXIC CYANOBACTERIA | 2016-09-08 |
| 20160256382 | SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY | 2016-09-08 |
| 20160256383 | COMPOSITIONS AND METHODS FOR COMBINATION INGREDIENT DELIVERY | 2016-09-08 |
| 20160256384 | DOSAGE FORM ARTICLES | 2016-09-08 |
| 20160256385 | GLUCAN GELS | 2016-09-08 |
| 20160256386 | METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY | 2016-09-08 |
| 20160256387 | DUAL LOADED LIPOSOMAL PHARMACEUTICAL FORMULATIONS | 2016-09-08 |
| 20160256388 | COMPOSITIONS AND METHODS FOR TREATMENT OF RESPIRATORY TRACT INFECTIONS | 2016-09-08 |
| 20160256389 | COMBINATION LIPOSOMAL PHARMACEUTICAL FORMULATIONS | 2016-09-08 |
| 20160256390 | PROCESS FOR PRODUCING CELLULOSE DERIVATIVES OF HIGH BULK DENSITY AND GOOD FLOWABILITY | 2016-09-08 |
| 20160256391 | PROCESS FOR THE PREPARATION OF A FREEZE-DRIED PHARMACEUTICAL COMPOSITION CONTAINING MITOMYCIN C | 2016-09-08 |
| 20160256392 | ABUSE-DETERRENT DOSAGE FORMS | 2016-09-08 |
| 20160256393 | GASTRORETENTIVE DRUG FORMULATION AND DELIVERY SYSTEMS AND THEIR METHOD OF PREPARATION USING FUNCTIONALIZED CALCIUM CARBONATE | 2016-09-08 |
| 20160256394 | PHARMACEUTICAL DOSAGE FORMS COMPRISING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-- PYRAZOL-5-OLATE | 2016-09-08 |
| 20160256395 | COMPRESSED TABLET CONTAINING DELTA 9-TETRAHYDROCANNABINOL, METHOD FOR ITS MANUFACTURE AND USE OF SUCH TABLET IN ORAL TREATMENT | 2016-09-08 |
| 20160256396 | Delayed Release Tablet With Defined Core Geometry | 2016-09-08 |
| 20160256397 | PHARMACEUTICAL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR | 2016-09-08 |
| 20160256398 | COMPOSITIONS OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)-PHENYL]PIPERAZINE | 2016-09-08 |
| 20160256399 | METHODS AND SYSTEMS FOR IMPROVED BIOAVAILABILITY OF ACTIVE PHARMACEUTICAL INGREDIENTS INCLUDING ESOMEPRAZOLE | 2016-09-08 |
| 20160256400 | CONTROLLED RELEASE COMPOSITIONS COMPRISING A COMBINATION OF ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE | 2016-09-08 |
| 20160256401 | TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS | 2016-09-08 |
| 20160256402 | SYNTHESIS OF HYPERBRANCHED AMPHIPHILIC POLYESTER AND THERANOSTIC NANOPARTICLES THEREOF | 2016-09-08 |
| 20160256403 | BIOCOMPATIBLE GRAPHENE QUANTUM DOTS FOR DRUG DELIVERY AND BIOIMAGING APPLICATIONS | 2016-09-08 |
| 20160256404 | Drugs and Gene Carrier Particles That Rapidly Move Through Mucous Barriers | 2016-09-08 |
| 20160256405 | STABILIZED COMPOSITIONS CONTAINING ALKALINE LABILE DRUGS | 2016-09-08 |
| 20160256406 | OLIGOMERIC/POLYMERIC SILICONE FLUIDS FOR USE IN TRANSDERMAL DRUG DELIVERY SYSTEMS | 2016-09-08 |
| 20160256407 | ENERGY PATCH | 2016-09-08 |
| 20160256408 | METHOD FOR STRESS MANAGEMENT AND OVERALL HEALTH STATUS IMPROVEMENT AND COMPOSITIONS USED THEREIN | 2016-09-08 |
| 20160256409 | METHOD FOR PROTECTION AND IMPROVEMENT OF LIVER HEALTH WITH MESO-ZEAXANTHIN COMPOSITIONS | 2016-09-08 |
| 20160256410 | TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY IN MAMMALS WITH CANNABINOIDS | 2016-09-08 |
| 20160256411 | TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY WITH CANNABINOIDS | 2016-09-08 |
| 20160256412 | METHOD TO SOLUBILIZE CURCUMINOIDS IN WATER | 2016-09-08 |
| 20160256413 | COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE | 2016-09-08 |
| 20160256414 | AMANTADINE COMPOSITIONS AND METHODS OF USE | 2016-09-08 |
| 20160256415 | TRANSMUCOSAL KETAMINE DELIVERY COMPOSITION | 2016-09-08 |
| 20160256416 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR | 2016-09-08 |
| 20160256417 | NOVEL TREATMENTS FOR ATTENTION AND COGNITIVE DISORDERS, AND FOR DEMENTIA ASSOCIATED WITH A NEURODEGENERATIVE DISORDER | 2016-09-08 |
| 20160256418 | METHODS FOR ADMINISTRATION AND FORMULATIONS FOR THE TREATMENT OF REGIONAL ADIPOSE TISSUE | 2016-09-08 |
| 20160256419 | APPLICATION OF FLUOXETINE TO TREATMENT OF DEPIGMENTATION DISEASES | 2016-09-08 |
| 20160256420 | Phosphate-Binding Magnesium Salts And Uses Thereof | 2016-09-08 |
| 20160256421 | COMPOSITION CONTAINING EUGENOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ATOPIC DERMATITIS | 2016-09-08 |
| 20160256422 | MEDICAMENT FOR THERAPEUTIC TREATMENT OF NEUROPATHIC DISEASE | 2016-09-08 |
| 20160256423 | COMPOSITION AND METHOD FOR INCREASING THE RATE OF ALCOHOL METABOLISM AND PREVENTING HANGOVER SYMPTOMS | 2016-09-08 |
| 20160256424 | OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES | 2016-09-08 |
| 20160256425 | Prostacyclin Compounds, Compositions and Methods of use Thereof | 2016-09-08 |
| 20160256426 | Composition preventing necrotic enteritis in galloanserans | 2016-09-08 |
| 20160256427 | HALOGENATED ESTERS OF CYCLOPROPANATED UNSATURATED FATTY ACIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2016-09-08 |
| 20160256428 | COMPOSITION CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT FOR INHIBITING BLOOD CANCER OR METASTASIS | 2016-09-08 |
| 20160256429 | COMPOUNDS AND COMPOSITIONS COMPRISING SUCH COMPOUNDS FOR THE PREVENTION OR TREATMENT OF DYSLIPIDAEMIAS | 2016-09-08 |
| 20160256430 | METHOD FOR TREATING SKIN INFLAMMATORY DISEASES | 2016-09-08 |
| 20160256431 | Cancer Treatments | 2016-09-08 |
| 20160256432 | COMPOSITIONS AND METHODS OF INHIBITING N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE | 2016-09-08 |
| 20160256433 | Formulations Containing Amorphous Dapagliflozin | 2016-09-08 |
| 20160256434 | USE OF STING AGONISTS TO TREAT HEPATITIS B VIRUS INFECTION | 2016-09-08 |
| 20160256435 | Composition with Pharmacological Effect for Vaporizing and Method | 2016-09-08 |
| 20160256436 | USE OF EQUOL FOR TREATING ANDROGEN MEDIATED DISEASES | 2016-09-08 |
| 20160256437 | METHODS OF TREATING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2016-09-08 |
| 20160256438 | CATALYTIC SCAVENGERS OF ORGANOPHOSPHATES TO POTENTIATE BUTYRYLCHOLINESTERASE (hBChE) AS A CATALYTIC BIOSCAVENGER AND METHODS FOR MAKING AND USING THEM | 2016-09-08 |
| 20160256439 | PREVENTION AND TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2016-09-08 |
| 20160256440 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN | 2016-09-08 |
| 20160256441 | MODULATION OF MRTF-A ACTIVITY IN PATHOLOGIC FIBROSIS AND WOUND HEALING | 2016-09-08 |
| 20160256442 | LONG-ACTING INJECTABLE FORMULATIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEROF | 2016-09-08 |
| 20160256443 | METHODS OF TREATING KERATIN HYPERPROLIFERATION DISORDERS USING mTOR INHIBITORS | 2016-09-08 |
| 20160256444 | METHOD AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF INFLAMMATORY CONDITIONS | 2016-09-08 |
| 20160256445 | DIHYDROPYRIDINONE MGAT2 INHIBITORS | 2016-09-08 |
| 20160256446 | METHODS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH HYPERLIPIDEMIA AND HYPERCHOLESTEROLEMIA WHILE MINIMIZING SIDE-EFFECTS | 2016-09-08 |
| 20160256447 | COMPOUNDS FOR MODULATING TRPV3 FUNCTION | 2016-09-08 |
| 20160256448 | TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS | 2016-09-08 |
| 20160256449 | H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE | 2016-09-08 |
| 20160256450 | COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS | 2016-09-08 |
| 20160256451 | DOSAGE OF NALOXONE | 2016-09-08 |
| 20160256454 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | 2016-09-08 |
| 20160256455 | Treating Pain In Patients With Hepatic Impairment | 2016-09-08 |
| 20160256457 | METHODS FOR TREATING OR PREVENTING ACUTE VASCULAR LEAK | 2016-09-08 |
| 20160256458 | BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS | 2016-09-08 |
| 20160256459 | SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRI- MIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE | 2016-09-08 |
| 20160256460 | ACTIVATORS OR STIMULATORS OF SOLUBLE GUANYLATE CYCLASE FOR USE IN TREATING CHRONIC FATIGUE SYNDROME | 2016-09-08 |
| 20160256461 | METHODS FOR TREATING HAIR LOSS DISORDERS | 2016-09-08 |
| 20160256462 | ORAL LIQUID PHARMACEUTICAL COMPOSITION OF A DPP-IV INHIBITOR | 2016-09-08 |
